Endometriosis is a debilitating disease characterized by the presence of functional endometrial glandular epithelium and stroma outside the uterine cavity that affects up to 20% of women of child-bearing age. Cyclooxygenase-2 (COX-2), a rate-limiting enzyme in the biosynthesis of prostaglandin E 2 (PGE 2 ), is highly expressed in endometriotic tissues and results in increased concentrations of peritoneal PGE 2 in women. In this study, we determined the expression of COX-2 protein in ectopic and eutopic endometria in humans and the role of COX-2 in endometriotic cell survival, migration, and invasion in humans. Our results indicate that COX-2 protein is abundantly expressed in ectopic endometria compared with eutopic endometria. Comparatively, expression of COX-2 protein is higher in eutopic endometria from women with endometriosis compared with women without endometriosis. Inhibition of COX-2 decreases survival, migration, and invasion of endometriotic cells that are associated with decreased production of PGE 2 . Cell growth inhibitory effects of COX-2 inhibition/silencing are mediated through nuclear poly (ADPribose) polymerase-mediated apoptosis. Cell motility and invasion inhibitory effects of COX-2 inhibition/silencing are mediated through matrix metalloproteinase-2 and -9 activities. Interestingly, effects of COX-2 inhibition is more profound in endometriotic epithelial than in stromal cells. Furthermore, inhibition of COX-2 affects invasion rather than migration of endometriotic epithelial and stromal cells. It is the first evidence showing that inhibition of COX-2 decreases endometriotic epithelial and stromal cell survival, migration, and invasion in humans. Our results support the emerging concept that COX-2/PGE 2 promotes the pathophysiology and pathogenesis of endometriosis in humans.
are targeted to inhibit ovarian activity and decrease ovarian estrogen production through the use of oral contraceptives, aromatase inhibitors, androgenic agents, and GnRH analogs or surgical removal of endometriotic tissues and uterus with or without ovary (1, 2, 6) . All of these treatments compromise pregnancy. Nevertheless, the recurrence rate is up to 50 -60% after cessation of therapy or surgery (1, 2) . Lack of understanding of molecular behavior of endometriotic cells remains a major limiting factor for development of better therapeutic interventions in women.
The pathophysiology of endometriosis remains an enigma in reproductive medicine. The most widely accepted hypothesis first advanced by Sampson (7) is that the viable endometrial tissue fragments are refluxed through the fallopian tubes into the pelvic cavity during retrograde menstruation. The typical characteristics of endometriotic cells include 1) steroidogenic potential, 2) continuous proliferation and resistance to apoptosis, 3) promoting neoangiogenesis, 4) migrating and invading, and 5) modulating the local immune system (1, 4, 5, 8, 9) . Endometriosis has been traditionally viewed as an estrogen-responsive disease (10) . However, recent reports suggest that endometriosis is both an estrogen-responsive and a progesterone-unresponsive disease (5) . A growing body of evidence indicates that growth factors, cytokines, and prostaglandins promote the establishment and maintenance of endometriosis (3, 9, (11) (12) (13) .
Prostaglandins (PGs) are central mediators that play major roles in several physiological and pathological processes in humans and animals (14 -16) . Arachidonic acid (AA), an essential fatty acid stored in membrane phospholipids, is the primary precursor of PGs. Cytosolic phospholipase A2 (PLA2) liberates AA from phospholipids. Cyclooxygenases (COXs) COX-1 and COX-2, convert AA into PGH 2 , the common precursor for various PGs (14) . PGH 2 is then converted into PGE 2, PGF 2␣ , PGI 2 (prostacyclin), PGD 2 , and thromboxane A2 by distinct PG synthases (14) . COX-2 is an inducible enzyme under physiological conditions (14) ; however, it is constitutively expressed in a variety of pathological conditions including cancers. PGE 2 exerts its biological effects through G protein-coupled receptors, designated EP1, EP2, EP3, and EP4, by activating multiple cell signaling pathways (15) . Recent studies indicate that EP receptors transactivate MAPK, AKT, and Wnt signaling pathways intracellularly, thereby regulating cell proliferation, apoptosis, migration and invasion, and angiogenesis, immunomodulation, and pain (16 -19) .
Concentrations of PGE 2 in peritoneal fluid are higher in women suffering from endometriosis than in disease-free women (20) . Much of the endometriotic pain is thought to be due to high levels of PGE 2 (21) . COX-2 is more abundantly expressed in ectopic endometria than in the eutopic endometria during similar phases of the menstrual cycle in women (22, 23) . COX-2 is expressed in both glandular epithelium and stroma of endometriotic tissues in women (22, 23) . Cytokines increase COX-2 expression in endometriotic stromal cells (3) . PGE 2 modulates expression of steroidogenic acute regulatory protein and aromatase in endometriotic stromal cells and thereby regulates estrogen metabolism (24) , which is primarily mediated through the EP2 receptor (25) . Moreover, inhibition of COX-2 prevents establishment of endometriosis (26, 27) , decreases size and number of endometriotic tissues (13, 26 -28) , and prevents neoangiogenesis in endometriotic implants (13, 27) in different animal models for study of endometriosis. Inhibition of COX-2 induces apoptosis in endometriotic cells through caspase-3 pathways (13) . We have recently shown that human immortalized endometriotic epithelial and stromal cells have migrating and invading potential that might be associated with increased PGE 2 production and matrix metalloproteinase-2 (MMP2) and MMP9 activities (29) .
Together, these results strongly suggest a requirement for COX-2 and PGE 2 in the pathophysiology and pathogenesis of endometriosis in women (3). However, the underlying mechanisms are largely unknown. Our objectives were to 1) determine the expression of COX-2 protein in ectopic and eutopic endometria in humans and 2) determine the relationship between COX-2/PGE 2 and endometriotic cell survival, migration, and invasion and underlying molecular and cellular mechanisms in humans. Our results indicate that inhibition of COX-2 decreases survival of endometriotic cell through poly-ADP-ribose polymerase (PARP)-mediated apoptosis and inhibits migration and invasion of endometriotic cells through MMP2-and MMP9-mediated mechanisms in humans.
Materials and Methods Materials
The reagents used in this study were purchased from the following suppliers: prestained protein markers and Bio-Rad assay reagents and standards from Bio-Rad Laboratories (Hercules, CA), Protran BA83 
Endometriotic and endometrial tissues
The following tissues were collected from women presented at the Obstetrics and Gynecology Unit and processed at the Anatomic Pathology Laboratory for diagnostic purposes, Scott & White Memorial Hospital, Texas A&M University System Health Science Center. 1) Ectopic endometria (endometriotic tissue, n ϭ 10) were collected from women with endometriosis and classified as stages I-IV based on criteria established by the American Society for Reproductive Medicine (30) . 2) Normal eutopic endometrial tissues (n ϭ 5) were collected from women undergoing hysterectomy for benign gynecological indications. 3) Eutopic endometria (n ϭ 5) were collected from women with endometriosis. All these women reported regular menstrual cycles (25-40 d cycle length) and no hormonal medication in the last 3 months. All the endometriotic and endometrial tissues were collected from the proliferative phase of the menstrual cycle. For the present study, additional sections were cut from these archived paraffin-embedded tissues that were not needed for patient care. These studies were approved by the Institutional Review Board of the Texas A&M University System Health Science Center.
Cell culture
Immortalized human endometriotic epithelial cells (12-Z, 49-Z, and 11-Z) and stromal cells (22-B) (8) and immortalized human endometrial surface epithelial cells (HES) (31) and stromal cells (HESC) (32) were used. HES cells were a generous gift from Dr. Asgerally T. Fazleabas, University of Illinois at Chicago, Chicago, IL. HESC cells were a generous gift from Dr. Graciela Krikun, Yale University, New Haven, CT. The endometriotic epithelial and stromal cells and normal endometrial epithelial and stromal cells were cultured in DMEM/F12 without special steroid treatment (Sigma) containing 10% FBS (Hyclone) and penicillin (100 U/ml), streptomycin (100 g/ml), and amphotericin-B 2.5 g/ml (Invitrogen) in a humidified atmosphere of 5% CO 2 and 95% air at 37 C as we described previously (29) .
COX-2 small interfering RNA (siRNA)
The cells (3.0 ϫ 10 5 per well) were cultured in antibiotic-free DMEM/ F12 with 10% FBS in six-well tissue culture plates. At 70 -80% confluency, cells were used for COX-2 knockdown experiments using COX-2 SMART-pool siRNA duplex delivered by DharmaFect-1 per manufacturer's instructions. As an internal control, siGLO RISC-Free siRNA or MOCK siRNA was used. COX-2 siRNA, siGLO RISC-free siRNA, and DharmaFect-1 were obtained from Dharmacon Inc. (Lafayette, CO). Briefly, siRNA duplexes (100 nm/well) and DharmaFect-1 (3 l/well) were diluted in 50 l antibiotic-and serum-free DMEM/F12 medium separately and mixed gently and incubated for 5 min at room temperature. Afterward, COX-2 siRNA and DharmaFect-1 were mixed (total volume 100 l) and incubated at room temperature for 20 min. Then, 100 l siRNA-DharmaFect-1 complex was diluted with 2 ml antibiotic-free medium with 10% FBS and added to the well. After 24 h, the medium was replaced with fresh DMEM/F12 with 10% FBS and incubated for 24 h. After 48 h of transfection, PGE 2 levels were measured by ELISA (33) , and endometriotic cell proliferation, apoptosis, migration and invasion were determined. Fluorescence-labeled siGLO RISC-free siRNA was transfected separately, and transfection efficiency was estimated using a fluorescence microscope. Efficiency of siRNA on COX-2 gene silencing was assessed by RT-PCR.
Cell proliferation assay
Endometriotic epithelial (12-Z, 49-Z, and 11-Z) and stromal (22-B) cells (10 ϫ 10 4 per well) were cultured in DMEM/F12 with 10% FBS in six-well plates. At 70 -80% of confluency, the cells were cultured in DMEM/F12 with 2% dextran charcoal-treated FBS and treated with NS-398 (100 m) for 36 h. The concentrations for NS-398 were determined by dose-response experiments using 25, 50, and 100 m (data not shown). At the end of experiments, adherent cells were washed with PBS and harvested using 0.1% trypsin-EDTA (Invitrogen). The cell pellets were resuspended in isotonic buffer (Val Tech Diagnostics Inc., Brackenridge, PA), and cell numbers were counted using a Coulter counter. Three experiments were conducted, and data are expressed as the mean Ϯ sem. To determine the effects of COX-2 siRNA on endometriotic cell proliferation, silencing of the COX-2 gene was performed as described above. After 24 h of transfection of COX-2 siRNA, the medium was replaced and the cells were cultured in 2% dextran charcoal-treated FBS, which was considered as time 0 h, and cell proliferation was estimated at 36 h as described above.
Terminal deoxynucleotide transferase dUTP nick end labeling (TUNEL) assay
Nonadherent and adherent cells were harvested, mixed together, and resuspended at the concentrations of 1 ϫ 10 6 cells/ml. Nicks in the DNA were determined by terminal deoxynucleotidyl transferase and 5-bromo-2Ј-deoxyuridine (BrdU) 5Ј-triphosphate labeling using APO-BrdU TUNEL Assay Kit (Molecular Probes, Carlsbad, CA). Detection of BrdU incorporation at DNA break sites was achieved through Alexa Fluor 488 dye-labeled anti-BrdU antibody. The staining procedures were followed as recommended by the manufacturers. The number of apoptotic cells was analyzed by a flow cytometer (FACSCaliber; Becton Dickinson, San Jose, CA) using Cell Quest software. In addition, the presence of TUNELlabeled DNA fragments and chromatin condensation was determined by fluorescence microscopy. Photos were captured using digital imaging and an image analysis workstation consisting of a Zeiss Axioplan 2 Research Microscope interfaced with a Zeiss Axiocam HR high resolution color CCD camera with Zeiss Axiovision (Carl Zeiss, Thornwood, NY).
Cell migration and invasion assays
In vitro migration and invasion assays were performed using uncoated or Matrigel-coated 24-well chambers/microfilters (8 m pore size polycarbonate filters), respectively, according to the manufacturer's instructions (BD Bioscience, Bedford, MA) and as described (29, 34, 35) . Briefly, after rehydration of the chambers, the cells (5 ϫ 10 4 cells per chamber) in 500 l DMEM/F12 plus 10% FBS were seeded onto the upper chamber. In the lower chamber, 500 l DMEM/F12 plus 10% FBS was placed. NS-398 (100 m) was added onto both upper and lower chambers. Endometriotic cell motility/migration was measured as number of cells migrated from a defined area of the uncoated microfilter through micropores in the given time, 24 h. Invasion of endometriotic cells was measured as number of cells invaded from a defined area of the Matrigel-coated microfilter through micropores in the given time, 24 h. The micropore filters were stained with 4Ј,6-diamidino-2-phenylindole (Vector), and cells migrated through filters were counted in eight representative areas per filter using a fluorescence microscope at ϫ400 magnification and expressed as the mean Ϯ sem of three independent experiments. To determine the effects of COX-2 siRNA on endometriotic cell migration and invasion, silencing of the COX-2 gene was performed as described above. After 24 h of transfection of siRNA, the medium was replaced and the cells were cultured in DMEM/F12 with 10% FBS. Adherent cells were harvested by trypsinization at 48 h after transfection of COX-2 siRNA and placed onto the upper chamber in DMEM/F12 with 10% FBS at the concentrations of 5 ϫ 10 4 cells per chamber. In the lower chamber, DMEM/F12 with 10% FBS was placed. The migration and invasion potential of endometriotic cells were determined as described above.
Gelatin zymography
MMP2 and MMP9 activity in the culture media was analyzed by zymography as we described recently (29) . Proteins in culture medium (25 l) were resolved on 7.5% SDS polyacrylamide gels (SDS-PAGE) (36) that were copolymerized with 0.1% (1 mg/ml) gelatin (29, 37, 38) . Proteolytic activity was detected by gelatin lysis as evidenced as clear bands against the blue background of stained gelatin. The gels were analyzed using AlphaImager software (Alpha Innotech Corp., San Leandro, CA), and densitometry was performed. Numerical values are expressed as mean Ϯ sem of three independent experiments.
Protein extraction and immunoblotting
Total protein was isolated from tissues and cells, and immunoblotting/Western blotting was performed as previously described (36, 39) . Protein concentration was determined using the Bradford method (40) and a Bio-Rad protein assay kit. Protein samples (50 g) were resolved using 10% SDS-PAGE. Primary antibodies for COX-2 (1:3000), PARP (1:1000), MMP2 (1: 1000), MMP9 (1:1000), or ␤-actin (1:5000) were used. Goat antirabbit IgG conjugated with horseradish peroxidase was used as the secondary antibody (1:10,000). Chemiluminescent substrate was applied according to the manufacturer's instructions. The blots were exposed to blue x-ray film, and densitometry of autoradiograms was performed using an Alpha Imager (Alpha Innotech).
Immunohistochemistry
Tissue sections were fixed in 4% buffered paraformaldehyde saline for 4 h at 4 C and processed using standard procedures (36) . Paraffin sections (5 m) were used for immunohistochemical localization of COX-2 protein using a Vectastain Elite ABC kit according to the manufacturer's protocols. The tissue sections were incubated with the COX-2 antibody at the concentrations of 1:500 overnight at 4 C. The tissue sections were further incubated with the secondary antibody (goat antirabbit IgG biotinylated, 1:200) for 30 min at room temperature. For the negative control, rabbit serum at the respective dilution was used. Between each step, tissue sections were washed in PBS. Photos were captured with the use of an Axioplan 2 Research Microscope (Carl Zeiss).
ELISA
Commercially available PGE 2 standards, antiserum, and acetylcholinesterase tracers were used (Cayman Chemicals, Ann Arbor, MI). ELISA was performed according to the manufacturers' instructions and as described previously (33) . Briefly, 50 l of culture medium collected from different experiments was used. The reaction mixture was incubated overnight at room temperature. Concentrations of PGE 2 were measured at 405 nm using a plate reader. A standard curve was developed with standards ranging from 50 -5000 pg PGE 2 /ml.
Statistical analyses
Statistical analyses were performed using general linear models of Statistical Analysis System (SAS, Cary, NC). Effects of inhibition of COX-2 on its protein expression, PGE 2 production, cell proliferation, apoptosis, migration, and invasion and expression and gelatinolytic activity of MMP2 and MMP9 in endometriotic cells were analyzed by one-way ANOVA followed by Tukey-Kramer honestly significant difference test. The relationship between PGE 2 concentrations and endometriotic cell proliferation, apoptosis, migration, and invasion were analyzed by simple linear correlation. The numerical data are expressed as mean Ϯ sem. Statistical significance was considered as P Ͻ 0.05.
Results

Expression of COX-2 protein in endometriotic tissues
Results (Fig. 1) indicated that COX-2 protein was expressed in glandular epithelia and stroma of ectopic endometria (endometriosis), eutopic endometria from women with endometriosis, and eutopic endometria from endometriosis-free women during the proliferative phase of the menstrual cycle. Interestingly, COX-2 protein was abundantly expressed in ectopic endometria compared with eutopic endometria. Furthermore, expression of COX-2 protein was relatively higher in eutopic endometria from women with endometriosis compared with women without endometriosis.
Regulation of COX-2 protein expression and PGE 2 production in endometriotic cells
We have recently characterized human immortalized endometriotic epithelial (12-Z, 49-Z, and 11-Z) and stromal (22-B) cells (8, 29) . We found that COX-2 gene was constitutively and abundantly expressed in these cell lines. In this study, we determined regulation of COX-2 protein and its functions. Results (Fig. 2 ) demonstrated that COX-2 protein was highly (P Ͻ 0.05) expressed in endometriotic epithelial (12-Z, 49-Z, and 11-Z) and stromal (22-B) cells compared with normal endometrial epithelial (HES) and stromal cells (HESC) under basal conditions. Endometriotic cells produced significant (P Ͻ 0.05) amounts of PGE 2 compared with normal endometrial cells. The quantity of PGE 2 production was associated with expression levels of COX-2 protein in these cells. Comparatively, endometriotic epithelial cells 12-Z and 11-Z produced (P Ͻ 0.05) a higher quantity of PGE 2 than endometriotic stromal cells 22-B. Pharmacological inhibition of COX-2 by its selective functional inhibitor NS-398 partly decreased (P Ͻ 0.05) the expression of COX-2 protein (ϳ2-to 3-fold) and inhibited (P Ͻ 0.05) PGE 2 production up to 90% in both endometriotic epithelial and stromal cells.
Association between COX-2/PGE 2 and endometriotic cell growth and proliferation
Inhibition of COX-2 by NS-398 decreased (P Ͻ 0.05) endometriotic epithelial and stromal cell proliferation (ϳ60 and ϳ40%, respectively) within 36 h of treatment (Fig. 3A) . However, the inhibitory effects of COX-2 were higher (ϳ20%, P Ͻ 0.05) in endometriotic epithelial cells than in stromal cells. PGE 2 levels were positively correlated (r ϭ 0.99; r ϭ 0.98) with proliferations of endometriotic epithelial and stromal cells, respectively.
Next, we determined whether the growth inhibitory mechanisms of COX-2 inhibition in endometriotic cells were associated with increased apoptosis. Therefore, we examined cleavage of PARP protein, a well-accepted marker for cell apoptosis (41) , in response to inhibition of COX-2 in endometriotic epithelial cells 12-Z and stromal cells 22-B. Results (Fig. 3 , B and C) indicated that inhibition of COX-2 by NS-398 cleaved PARP protein within 24 h of treatment in both 12-Z and 22-B cells. Consistent with these findings, the TUNEL assay (Fig. 3, D and E) using flow cytometry indicated that inhibition of COX-2 by NS-398 increased (P Ͻ 0.05) apoptosis of both 12-Z and 22-B cells within 24 h. Interestingly, cell apoptosis was higher (200%, P Ͻ 0.05) in endometriotic epithelial cells 12-Z compared with stromal cells 22-B. TUNEL assay based on fluorescence microscopy clearly showed that inhibition of COX-2 induced DNA fragmentation and chromatin condensation in both 12-Z and 22-B cells within 24 h of treatment (Fig. 3F) . PGE 2 production levels were negatively correlated (r ϭ Ϫ0.98; r ϭ Ϫ0.97) with apoptosis of 12-Z and 22-B cells, respectively.
Association between COX-2/PGE 2 and endometriotic cell migration and invasion
Results indicated that inhibition of COX-2 by NS-398 decreased (P Ͻ 0.05) endometriotic epithelial and stromal cell migration approximately 55 and 35%, respectively (Fig. 4, A  and B) . Inhibition of COX-2 decreased invasion of endometriotic epithelial and stromal cells approximately 65 and 45%, respectively (Fig. 4, C and D) . Effects of COX-2 inhibition on migration and invasion potential were higher (ϳ20%, P Ͻ 0.05) in endometriotic epithelial cells compared with stromal cells. Interestingly, effects of COX-2 inhibition on endometriotic cells invasion were higher (ϳ10%, P Ͻ 0.05) than on migration. Concentrations of PGE 2 were positively correlated with migration (r ϭ 0.98) and invasion (r ϭ 0.97) of endometriotic cells.
Then, we examined whether the inhibitory effects of
Immunohistochemical localization of COX-2 protein in ectopic and eutopic endometria in human. A, Negative control; B, ectopic endometrium (endometriosis); C, eutopic endometrium from women with endometriosis; D, eutopic endometrium from women without endometriosis. COX-2 protein was expressed in glandular epithelium (GLE) and stroma (STR). Ectopic endometria (n ϭ 10), eutopic endometria with endometriosis (n ϭ 5), and normal eutopic endometria (n ϭ 5) were collected during the proliferative phase of the menstrual cycle. Representative immunohistochemistry pictures at ϫ400 magnification are shown. Immunohistochemistry was performed using Vectastain Elite ABC kit according to the manufacturer's protocols. Please see Materials and Methods for more details.
COX-2 on endometriotic cell migration and invasion were associated with metalloproteinases MMP9 and MMP2, the well-studied markers for cell migration and invasion (42) . We used endometriotic epithelial cells 12-Z and stromal cells 22-B as representative cell lines. First, we examined regulation of total MMP9 and MMP2 proteins in whole-cell lysate using Western blot. Results (Fig. 4 , E and F) indicated that inhibition of COX-2 with NS-398 decreased (P Ͻ 0.05) the expression of total MMP9 and MMP2 proteins (the antibodies used detect total MMP9 and MMP2 proteins including pro-and active forms). Next, we determined secretion and activity of MMP9 and MMP2 proteins. Culture media were harvested during the migration and invasion assay, and activities of MMP9 and MMP2 proteins were analyzed by gelatin zymography. The detection limits for pro-and active forms of MMP9 and MMP2 proteins and their gelatinolytic activities by zymography in these experiments were in agreement with the previous reports (37, 38) . Results (Fig. 4, G 
Effects of COX-2 siRNA on endometriotic cell survival, migration, and invasion
Finally, we confirmed the role of COX-2 in endometriotic cell proliferation, migration, and invasion by a genomics approach using siRNA. We used endometriotic epithelial cells 12-Z and stromal cells 22-B as representative cell lines. The success of siRNA transfection was 85-90%, and COX-2 gene silencing was up to about 80% in 12-Z and 22-B cells. Results from COX-2 gene knockdown experiments indicated that silencing of COX-2 gene decreased (P Ͻ 0.05) PGE 2 production about 85% in 12-Z and 22-B cells (Fig. 5A) , proliferation of 12-Z cells about 53% and 22-B cells about 38% (Fig. 5B) , migration of 12-Z and 22-B cells about 50 and 35%, respectively (Fig. 5C) , and invasion of 12-Z and 22-B cells 60 and 40%, respectively (Fig. 5D) . Concentrations of PGE 2 were positively correlated with endometriotic cell proliferation (r ϭ 0.99), migration (r ϭ 
Discussion
In the present study, we determined a role for COX-2 in endometriotic cell proliferation, survival, migration, and invasion using pharmacological and genomic approaches. It is the first evidence showing that inhibition of COX-2 1) decreased endometriotic epithelial and stromal cells survival by inducing PARP-mediated apoptosis and 2) inhibited en- Representative Western blots, TUNEL assay DNA histogram, and fluorescence microscopy photomicrographs at ϫ400 are shown. Cell proliferation was determined using a Coulter counter. Cell apoptosis was determined using APO-BrdU TUNEL Assay Kit. CONT, Control; IDV, integrated density value. Numerical data are expressed as mean Ϯ SE of three independent experiments. Please see Materials and Methods for more details.
dometriotic epithelial and stromal cells migration and invasion through MMP2-and MMP9-mediated mechanisms in human. Our results support the emerging concept that PGE 2 promotes the pathophysiology and pathogenesis of endometriosis in human (3).
COX-2 protein is more abundantly expressed in ectopic endometria than in eutopic endometria, which is consistent with the previous reports (22, 23) . In eutopic endometria, COX-2 protein is highly expressed in women with endometriosis compared with disease-free women. This result is in agreement with the emerging hypothesis that the presence of endometriotic lesions alters functions of eutopic endometrium (4). Increased expression of COX-2 protein in endometriosis suggests its important role in pathophysiology and pathogenesis of this disease. PGE 2 is an important mediator that regulates cell proliferation, apoptosis, migration, and invasion in several cell types (16) . We used recently characterized immortalized human endometriotic epithelial and stromal cells (8, 29) to examine COX-2 functions and PGE 2 biosynthesis. COX-2 protein is constitutively but very abundantly expressed in these cells, and they produce large amounts of PGE 2 . Com- paratively, the level of PGE 2 production is higher in epithelial than in stromal cells. Inhibition of COX-2 by its selective inhibitor NS-398 and siRNA significantly decrease PGE 2 production in both endometriotic epithelial and stromal cells. These results suggest that COX-2 is the rate-limiting enzyme in PGE 2 biosynthesis in endometriotic epithelial as well as stromal cells in human.
In the process of deciphering interactions between COX-2 and endometriosis, first we determined whether the increased COX-2 protein expression and PGE 2 production in human endometriotic cells were associated with their survival. Results indicate that inhibition of COX-2 by NS-398 and siRNA significantly decreases PGE 2 production and endometriotic epithelial and stromal cell proliferation. Nuclear PARP maintains the viability of the cells under normal physiological conditions. By contrast, in response to apoptotic stimuli, caspase-3 cleaves PARP protein, which in turn facilitates DNA repair and cellular disassembly and serves as the marker of cells undergoing apoptosis (41) . Therefore, we determined a role for PARP protein in endometriotic cell apoptosis. Inhibition of COX-2 cleaves PARP protein, induces DNA fragmentation and chromatin condensation, and increases apoptosis of endometriotic epithelial and stromal cells. Together, these results suggest that PGE 2 promotes survival and growth of human endometriotic epithelial and stromal cells. Available evidence clearly indicates that inhibition of COX-2 increases apoptosis by altering interactions between antiapoptotic and proapoptotic members and mitochondrial membrane integrity and release of cytochrome c and activation of caspase 3 and PARP proteins (43) and induces cell cycle arrest either in G0-G1 or G2-M phase by altering several cell cycle regulatory genes such as cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors p21 and p27 (44) . Several cell cycle regulatory genes are expressed in these endometriotic epithelial and stromal cells (29) . Further studies are required to identify and decipher mechanisms and interactions between COX-2 pathways and cell cycle and apoptotic machinery in these endometriotic cells.
Second, we determined whether the increased COX-2 expression and PGE 2 production in human endometriotic cells were associated with their migration and invasion potential. Results indicate that endometriotic epithelial and stromal cells do have potential to migrate and invade, and endometriotic stromal cells possess more migrating and invading potential than epithelial cells, which is in consistent with our previous report (29) . This difference might be due to the inherent nature of these two cell types. Surprisingly, inhibition of COX-2 by NS-398 and siRNA significantly decreases migration and invasion potential in both endometriotic epithelial and stromal cells; however, the effects are more profound in epithelial than in stromal cells, which are associated with quantity of PGE 2 they produced. Furthermore, an interesting observation is that inhibition of COX-2 produces more detrimental effects on invasion compared with migration of endometriotic cells; however, the underlined molecular mechanisms for these selective effects are unknown. These results suggest that PGE 2 promotes migration/motility and invasion of human endometriotic epithelial and stromal cells. Recent studies have reported that inhibition of COX-2 decreases invasiveness and establishment of endometriosis in rodent models (13, 26 -28) , and endometriotic/ endometrial cells invade peritoneal mesothelial cells in vitro (9, 45) , which might require activation of MMPs (46, 47) .
MMPs are important enzymes in the degradation and reconstruction of the extracellular matrix (ECM), which is the prerequisite for the process of cell migration and invasion (42) . MMP2 and MMP9 are most consistently detected in malignant tissues and are associated with tumor aggressiveness and metastatic potential (42) . Therefore, we determined whether the inhibitory effects of COX-2 inhibition were mediated through MMP2 and MMP9 proteins. Results indicate that endometriotic epithelial and stromal cells secrete MMP2 and MMP9 proteins, which is consistent with our previous report (29) . Inhibition of COX-2 by NS-398 decreases synthesis and gelatinolytic activities of MMP2 and MMP9 proteins, which is associated with decreased production of PGE 2 in both endometriotic epithelial and stromal cell types. It suggests that PGE 2 promotes the secretion/release of MMP2 and MMP9 proteins in endometriotic epithelial and stromal cells, and inhibitory effects of COX-2 on migration and invasion potential of endometriotic epithelial and stromal cell are partly mediated through MMP2 and MMP9. Our results are in agreement with previously published data for other cell types that COX-2 and PGE 2 promote the secretion of MMP2 and MMP9 and pharmacological inhibition of COX-2 with NS-398 prevents the release of MMP2 and MMP9 (48) , and inhibition COX-2 decreases expression and release of MMPs and associated cell migration and invasion (49) .
It is well accepted that MMP2, MMP9, and other MMPs play an important role in cell migration and invasion (42) . Synthesis and activation of MMPs exquisitely regulate degradation of ECM. The regulation of MMP synthesis and activation is both tissue/cell and MMP specific. In response to stimuli, specific MMP mRNA is synthesized, and this mRNA will be translated into a latent or pro form of the MMP protein. The majority of the pro-MMPs are secreted from the cells in a latent form that will be activated (active MMP) in the extracellular space by a variety of other proteases. This active MMP is capable of degrading ECM, and alternatively, this active MMP can be bound with its endogenous inhibitors such as tissue inhibitors of metalloproteinases (TIMPs) (50) . The role of MMPs and TIMPs in endometrial biology has been extensively reviewed recently (50) . A role for MMP3 and MMP7 in the pathophysiology of endometriosis has already been reported (51) . The endometriotic cells used in the present study express MMP1, MMP3, MMP7, TIMP1, TIMP2, and TIMP3 genes at various levels (29) . Further studies using these cell lines will determine interactions among MMPs, TIMPs, and PGE 2 and their important roles in pathophysiology and pathogenesis of endometriosis in humans.
It is well known that COX-2-derived PGE 2 is involved in the pathophysiology and pathogenesis of various cancers (16) . Use of selective COX-2 inhibitors such as celecoxib, rofecoxib, and valdecoxib to inhibit PGE 2 production has produced remarkable effects on remission of colon as well as other cancers (18) . Unfortunately, therapeutic use of COX-2 inhibitors has been suspended because of undesirable cardiovascular side effects (18) , which might be due to inhibition of other PGs such as PGI 2 and thromboxane A2 but not due to inhibition of PGE 2 (18) . It challenges us to discover alternative targets downstream of COX-2 to inhibit selective biosynthesis, catabolism, and signaling of PGE 2 (16, 18) . In endometriotic women, peritoneal fluid concentrations of PGE 2 are higher compared with disease-free women (20) . Much of the endometriotic pain is thought to be due to high levels of PGE 2 (21) . Inhibition of COX-2 prevents the establishment of endometriosis (26, 27) and decreases the size and number of endometriotic tissues (13, 26 -28) . Taken together, the present results along with the findings from other laboratories (3, 13, 26 -28) very strongly indicate that PGE 2 has a profound role in pathophysiology and pathogenesis of endometriosis and also suggest that endometriosis is a PGE 2 -dependent disease. Ongoing studies determining a role for PGE synthases, PG dehydrogenases, and PGE 2 receptors downstream of COX-2 may provide new information to control the selective production and action of PGE 2 in endometriotic cells, and that may yield better therapeutic modalities for treatment of endometriosis in human.
In conclusion, results from the present study suggest that 1) COX-2 protein is highly expressed in endometriotic tissues; 2) increased expression of COX-2 and production of PGE 2 regulate survival, migration, and invasion of endometriotic epithelial and stromal cells in human; and 3) inhibition of COX-2 by pharmacological and genomic approaches decreases growth, migration, and invasion of endometriotic epithelial and stromal cells in humans.
